The board of directors of WuXi Biologics (Cayman) Inc. announced that, with effect from August 23, 2021, Mr. Ming Tu has been appointed as the Co-Chief Financial Officer reporting to Ms. Christine Lu-Wong, the Chief Financial Officer and Executive Vice President of the Group. Mr. Tu will be primarily responsible for leading all aspects of the Company's financial strategy, performance, reporting and business planning, as well as functional support, such as treasury, tax, controllership and audit operations.